期刊文献+

重症肌无力患者围术期麻醉管理的进展

下载PDF
导出
摘要 重症肌无力(myasthenia gravis,MG)是一种由抗体介导的乙酰胆碱(Ach)受体(AchR)受损和功能性AchR减少的自身免疫性疾病,其临床特征是骨骼肌无力和易疲劳,活动后症状加重,休息或予胆碱酯酶抑制剂治疗后可缓解。
出处 《上海医学》 CAS CSCD 北大核心 2015年第4期331-335,共5页 Shanghai Medical Journal
基金 安徽省卫生厅医学科研项目资助(2010C066)
  • 相关文献

参考文献35

  • 1JAMAL B T, HERB K. Perioperative management of patients with myasthenia gravis: prevention, recognition, and treatment[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 107(5): 612-615.
  • 2PHILLIPS L H 2nd. The epidemiology of myasthenia gravis [J]. AnnN YAcad Sci, 2003, 998: 407-412.
  • 3CAVALCANTE P, CUFI P, MANTEGAZZA R, et al. Etiology of myasthenia gravis: innate immunity signature in pathological thymus [J]. Autoimmun Rev, 2013, 12 (9) : 863-874.
  • 4DAN D, BART P A, NOVY J, et al. Double seronegative myasthenia gravis with antiphospholipid syndrome: a case report[J/OL]. J Med Case Rep, 2014, 8: 2[2014-01-01]. http ://www. jmedicalcasereports, com/content/8/1/2.
  • 5LE PANSE R, BERRIH-AKNIN S. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation[J]. Curt Opin Neurol, 2013, 26(5): 569-576.
  • 6VINCENT A, BOWEN J, NEWSOM-DAVIS J, et al. Seronegative generalized myasthenia gravis : clinical features, antibodies, and their targets[J]. Lancet Neurol, 2003, 2(2): 99-106.
  • 7ONODERA H. The role of the thymus in the pathogenesis of myasthenia gravis[J]. Tohoku J Exp Med, 2005, 207 (2) : 87-98.
  • 8SANDERS D B, EL-SALEM K, MASSEY J M, et al. Clinical aspects of MuSK antibody positive seronegative MG [J]. Neurology, 2003, 60(12): 1978-1980.
  • 9BLICHFELDT-LAURIDSEN L, HANSEN B D. Anesthesia and myasthenia gravis [J]. Acta Anaesthesiol Scand, 2012, 56(1): 17-22.
  • 10GRITTI P, SGARZI M, CARRARA B, et al. A standardized protocol for the perioperative management of myasthenia gravis patient. Experience with 110 patients[J]. Acta Anaesthesiol Stand, 2012, 56(1): 66-75.

二级参考文献27

  • 1应俊,吴敏,朱晓红,卢忆梅,陈受琳.罗库溴铵不同维持给药方法的药效动力学比较[J].实用临床医学(江西),2005,6(5):56-57. 被引量:3
  • 2Drachman DB. Myasthenia gravis. N Engl J Med, 1994, 330: 1797-1810.
  • 3Kampe S, Kiencke P, Krombach J, et al. Current practice in postoperative epidural analgesia: a German survey. Anesth Analg, 2002,95: 1767-1769.
  • 4Chevalley C, Spiliopoulos A, de Perrot M, et al. Perioperative medical management and outcome following thymectomy for myasthenia gravis.Can J Anaesth, 2001, 48: 446-451.
  • 5Lee WK, Li CH, Lee LS, et al. Epidural ropivaeaine for postoperative analgesia in Taiwan Residents patients. Acta Anaesthesiol Sin, 2003, 41: 21-25.
  • 6Houmes RJ, Voets MA, Verkaaik A, et al. Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg, 1992, 74: 510-514.
  • 7Whiteside R, Jones D, Bignell S, et al. Epidural ropivaeainc with fentanyl following major gynaecological surgery : the effect of volume and concentration of pain relief and motor impairment. Br J Anaesth, 2000,84 : 720-724.
  • 8Jin F, Chung F. Multimodal analgesia for postoperative pain control. J Clin Anesth, 2001, 13: 524-539.
  • 9Suwanchinda V, Yok Ubol B, Prakanrattana U, et al. Combined thoracic epidural with light general anesthesia for thymectomy in myasthenia gravis. J Mad Assoc Thai, 1995, 78 : 605-610.
  • 10Pang WW, Mok MS, Lin CH, et al. Comparison of patient-controlled analgesia with tramadol or morphine. Can J Anaesth, 1999, 46: 1030-1035.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部